A new COVID-19 therapeutic discovered using a mouse model was found to neutralize all tested COVID-19 variants, including Wuhan, Alpha, Delta, Mild Omicron (BA.1, BA.2, BA.4, BA.5).
The researchers found a monoclonal antibody that targeted a different area of the virus than many of the previous monoclonal antibodies. It inhibited SARS-CoV-2’s ability to fuse with the human cell wall, rather than many of the previous antibodies that inhibited the virus’s ability to bind to the human cell receptors.
Given this, it has robust treatment potential for current and future variants. Additionally, some have postulated whether this would be a better vaccine target that may eliminate the need to have booster vaccinations. We discuss all of this and more!
Click this link for the original source of this article.
Author: covid 19 updates
This content is courtesy of, and owned and copyrighted by, https://covid19updates.org and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.